# Double Cord Versus Haploidentical (BMT CTN 1101)

> **NCT01597778** · PHASE3 · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 368 (actual)

## Conditions studied

- Acute Lymphocytic Leukemia
- Acute Myelogenous Leukemia
- Burkitt's Lymphoma
- Follicular Lymphoma
- Hodgkin Lymphoma
- Mantle Cell Lymphoma
- Non-Hodgkin Lymphoma

## Interventions

- **BIOLOGICAL:** Haploidentical Bone Marrow Transplant
- **BIOLOGICAL:** Double Umbilical Cord Blood Transplant

## Key facts

- **NCT ID:** NCT01597778
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2020-09-11
- **Final completion:** 2020-09-11
- **Target enrollment:** 368 (ACTUAL)
- **Last updated:** 2021-12-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01597778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01597778, "Double Cord Versus Haploidentical (BMT CTN 1101)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01597778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*